{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T06:52:09Z","timestamp":1763016729950},"reference-count":25,"publisher":"Hindawi Limited","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3121,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1742-1241.2007.01284.x","type":"journal-article","created":{"date-parts":[[2007,2,15]],"date-time":"2007-02-15T01:33:44Z","timestamp":1171503224000},"page":"403-410","source":"Crossref","is-referenced-by-count":11,"title":["A 2-year open-label study of galantamine therapy in Chinese Alzheimer's disease patients in Hong Kong"],"prefix":"10.1155","volume":"61","author":[{"given":"L. W.","family":"Chu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Y.","family":"Yik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Mok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. P.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2007,2,14]]},"reference":[{"key":"10.1111\/j.1742-1241.2007.01284.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1056\/NEJMra040223","article-title":"Drug therapy: Alzheimer's disease","volume":"351","author":"Cummings","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2007.01284.x-BIB2|cit2","first-page":"9","volume-title":"Alzheimer Disease","author":"Berg","year":"1996"},{"issue":"Suppl. 1","key":"10.1111\/j.1742-1241.2007.01284.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1017\/S1041610203008652","article-title":"The ABC of Alzheimer's disease: behavioral symptoms and their treatment","volume":"14","author":"Grossberg","year":"2002","journal-title":"Int Psychogeriatr"},{"key":"10.1111\/j.1742-1241.2007.01284.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0014-2999(00)00093-5","article-title":"Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer's disease","volume":"393","author":"Maelicke","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/j.1742-1241.2007.01284.x-BIB5|cit5","first-page":"781","article-title":"Galantamine and the treatment of Alzheimer's disease","volume":"8","author":"Wilcock","year":"1993","journal-title":"Int J Geriatric Psychiatry"},{"key":"10.1111\/j.1742-1241.2007.01284.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1212\/WNL.54.12.2269","article-title":"A 5-month placebo-controlled trial of galantamine in AD","volume":"54","author":"Tariot","year":"2000","journal-title":"Neurology"},{"key":"10.1111\/j.1742-1241.2007.01284.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1212\/WNL.54.12.2261","article-title":"Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension","volume":"54","author":"Raskind","year":"2000","journal-title":"Neurology"},{"key":"10.1111\/j.1742-1241.2007.01284.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1136\/bmj.321.7274.1445","article-title":"Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomized controlled trial","volume":"321","author":"Wilcock","year":"2000","journal-title":"BMJ"},{"key":"10.1111\/j.1742-1241.2007.01284.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1468-1331.2004.00885.x","article-title":"Long-term efficacy and safety of galantamine in patients with mild-to-moderate Alzheimer's disease: multicenter trial","volume":"11","author":"Pirttila","year":"2004","journal-title":"Eur J Neurol"},{"key":"10.1111\/j.1742-1241.2007.01284.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1368-5031.2006.00892.x","article-title":"Efficacy study of galantamine in possible Alzheimer's disease with or without cerebrovascular disease and vascular dementia in Thai patients: a slow-titration regimen","volume":"60","author":"Thavichachart","year":"2006","journal-title":"Int J Clin Pract"},{"key":"10.1111\/j.1742-1241.2007.01284.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1111\/j.1742-1241.2007.01284.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-mental state. A practical method for grading the cognitive status of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.1111\/j.1742-1241.2007.01284.x-BIB13|cit13","first-page":"25","article-title":"Reliability and validity of the cantonese version of Mini-Mental State Examination - a preliminary study","volume":"4","author":"Chiu","year":"1994","journal-title":"J Hong Kong Coll Psychiatr"},{"key":"10.1111\/j.1742-1241.2007.01284.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1176\/ajp.141.11.1356","article-title":"A new rating scale for Alzheimer's disease","volume":"141","author":"Rosen","year":"1984","journal-title":"Am J Psychiatry"},{"key":"10.1111\/j.1742-1241.2007.01284.x-BIB15|cit15","first-page":"478","article-title":"The reliability and validity of the Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS-cog) among the elderly Chinese in Hong Kong","volume":"29","author":"Chu","year":"2000","journal-title":"Ann Acad Singapore"},{"key":"10.1111\/j.1742-1241.2007.01284.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"issue":"Suppl. 2","key":"10.1111\/j.1742-1241.2007.01284.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1097\/00002093-199700112-00005","article-title":"An inventory to assess the activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study","volume":"11","author":"Galasko","year":"1997","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1111\/j.1742-1241.2007.01284.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.clinthera.2004.10.006","article-title":"A prospective, double-blind, community-controlled comparison of three doses of galantamine in the treatment of mild to moderate Alzheimer's disease in a Korean population","volume":"26","author":"Suh","year":"2004","journal-title":"Clin Ther"},{"key":"10.1111\/j.1742-1241.2007.01284.x-BIB19|cit19","first-page":"1","article-title":"Outcome measures in Alzheimer's disease","author":"McKeith","year":"1999","journal-title":"Martin Dunitz"},{"key":"10.1111\/j.1742-1241.2007.01284.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1176\/ajp.151.3.390","article-title":"A longitudinal study of Alzheimer's disease: measurement, rate and predictors of cognitive deterioration","volume":"151","author":"Stern","year":"1994","journal-title":"Am J Psychiatry"},{"key":"10.1111\/j.1742-1241.2007.01284.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/01.wad.0000127445.00442.a1","article-title":"Disease stage in Alzheimer disease and treatment effects of rivastigmine","volume":"18","author":"Kurz","year":"2004","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1111\/j.1742-1241.2007.01284.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/00002093-200110000-00003","article-title":"The Alzheimer's Disease Assessment Scale: evaluation of psychometric properties and patterns of cognitive decline in multicenter clinical trials of mild to moderate Alzheimer's disease","volume":"15","author":"Murali Doraiswamy","year":"2001","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1111\/j.1742-1241.2007.01284.x-BIB23|cit23","first-page":"21","article-title":"Clinical features of Alzheimer's disease in a regional Memory Clinic in Hong Kong","volume":"11","author":"Chiu","year":"2002","journal-title":"J Hong Kong Geriatr Soc"},{"key":"10.1111\/j.1742-1241.2007.01284.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/gps.1207","article-title":"The relationship between non-cognitive symptoms and functional impairment in Alzheimer's disease","volume":"19","author":"Mok","year":"2004","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1111\/j.1742-1241.2007.01284.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/j.1532-5415.1992.tb01992.x","article-title":"The Mini-Mental State Examination: a comprehensive review","volume":"40","author":"Tombaugh","year":"1992","journal-title":"J Am Geriatr Soc"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2007.01284.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1742-1241.2007.01284.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:04:52Z","timestamp":1643349892000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-1241.2007.01284.x"}},"subtitle":["Galantamine therapy in Chinese AD patients"],"short-title":[],"issued":{"date-parts":[[2007,2,14]]},"references-count":25,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.1111\/j.1742-1241.2007.01284.x","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2,14]]}}}